You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORIC Sale Disclosure
Heyman Richard A. · SEC Form 4 · Filed Jul 28, 2026
Sale
Calculated transaction value
$84.14K
Heyman Richard A. Director
ORIC
Oric Pharmaceuticals
ORIC
Transaction date
Jul 24, 2026
Public filing date
Jul 28, 2026
Filing lag
Filed 4 days later
ORIC daily price context
Close on/before transaction
$12.1
Jul 24, 2026
First close after public filing
$11.28
Jul 29, 2026
30-day return after filing
+21.81%
Through Aug 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,000 shares @ $12.02
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001584759-26-000015
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$163.06K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. ORIC | Exercise | Jul 24, 2026 | $5.6K |
| Oric Pharmaceuticals, Inc. ORIC Current | Sale | Jul 24, 2026 | $84.14K |
| Oric Pharmaceuticals, Inc. ORIC | Exercise | Jul 24, 2026 | $0 |
| Oric Pharmaceuticals, Inc. ORIC | Sale | Jul 24, 2026 | $73.32K |